4O Liquid biopsy-guided selection for anti-EGFR re-treatment in RAS/BRAF wild-type (wt) chemorefractory metastatic colorectal cancer patients (mCRC pts): Results from the phase II randomized PARERE trial.
Saved in:
| Title: | 4O Liquid biopsy-guided selection for anti-EGFR re-treatment in RAS/BRAF wild-type (wt) chemorefractory metastatic colorectal cancer patients (mCRC pts): Results from the phase II randomized PARERE trial. |
|---|---|
| Authors: | Ciracì, P.1 (AUTHOR), Germani, M.M.1 (AUTHOR), Pietrantonio, F.2 (AUTHOR), Lonardi, S.3 (AUTHOR), Busico, A.4 (AUTHOR), Chiaramonte, A.2 (AUTHOR), Ricagno, G.5 (AUTHOR), Esposto, R.6 (AUTHOR), Formica, V.7 (AUTHOR), Scartozzi, M.8 (AUTHOR), Burgio, V.9 (AUTHOR), Di Donato, S.10 (AUTHOR), Moretto, R.11 (AUTHOR), Capone, I.4 (AUTHOR), Bertuzzi, F.2 (AUTHOR), Marmorino, F.1 (AUTHOR), Taravella, A.1 (AUTHOR), Boni, L.12 (AUTHOR), Rossini, D.13 (AUTHOR), Cremolini, C.1 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 1, Vol. 36, pS4-S4. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.05.016 |
